However, based on bioinformatics analysis, we first supposed that DDX42 might be involved in the cell proliferation and treatment resistance phenotypes by urging the maturation process of GRB2, which has been fully understood in several tumour types. The gene discussed is GRB2; the disease is neoplasm.